Synnovis and SOPHiA GENETICS Partner to Bring Blood-based Cancer Testing to Patients Across the U.K.

Go back to Synnovis and SOPHiA GENETICS Partner to Bring Blood-based Cancer Testing to Patients Across the U.K.
(NASDAQ: SOPH) Delayed: 5.30 -0.04 (0.75%)
Previous Close $5.34    52 Week High
Open $5.29    52 Week Low
Day High $5.35    P/E N/A 
Day Low $5.22    EPS
Volume 18,072